Japan requiring domestic clinical trials before giving coronavirus vaccines the green light

(Natural News) The rollout of Wuhan coronavirus (COVID-19) vaccines in Japan has been delayed due to the country’s insistence on running domestic clinical trials before it approves any vaccine. The one outstanding condition Japan requires from Moderna, BioNTech-Pfizer, AstraZeneca and several other pharmaceutical companies is that they conduct small clinical trials on Japanese citizens that demonstrate the...